Tscan Therapeutics, Inc.
Clinical trials sponsored by Tscan Therapeutics, Inc., explained in plain language.
-
Custom immune cells take on multiple cancers in early trial
Disease control OngoingThis early-stage study tests a new treatment called T-Plex for people with advanced solid tumors (like head and neck, cervical, or melanoma) that haven't responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and…
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Genetic screening opens door to personalized cancer treatments
Knowledge-focused OngoingThis study screens up to 1,150 adults with advanced solid tumors like head and neck, cervical, or lung cancer. Researchers collect blood or tissue samples to check for specific genetic markers and tumor proteins. The goal is to identify patients who might be eligible for future t…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC